AFP and neoplasm: The serum level changes of characteristic tumor markers (such as CEA in colon cancer, AFP in liver cancer, and PSA in prostate cancer) of various types of tumors after the treatment with PD-1 inhibitors were compared with the evaluation results of RECIST standard and HPD standard in this study.